2,4-Dimethylbenzaldehyde → HCID 11454345, compound
Reaction equation
C(O[C:9](=O)[NH:10][CH2:11][C@H:12]([NH:18][C:19](=[O:33])[CH2:20][C:21](=[O:32])[NH:22][C:23]1[S:24][C:25]([C:28]([CH3:31])([CH3:30])[CH3:29])=[N:26][N:27]=1)[C@@H:13]([OH:17])[C:14]#[C:15][CH3:16])C1C=CC=CC=1.[CH3:35][C:36]1[CH:43]=[C:42]([CH3:44])[CH:41]=[CH:40][C:37]=1C=O.C([BH3-])#N.[Na+]>CO.[Pd]>[C:28]([C:25]1[S:24][C:23]([NH:22][C:21](=[O:32])[CH2:20][C:19]([NH:18][C@@H:12]([CH2:11][NH:10][CH2:9][C:37]2[CH:40]=[CH:41][C:42]([CH3:44])=[CH:43][C:36]=2[CH3:35])[C@@H:13]([OH:17])[CH2:14][CH2:15][CH3:16])=[O:33])=[N:27][N:26]=1)([CH3:29])([CH3:30])[CH3:31]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
The compound 5-tert-butyl-[1,3,4]thiadiazol-2-ylamine (67 mg, 0.43 mmol) was dissolved in 6 mL of 1:1 CH2Cl2/DMF. The resultant solution was charged sequentially with the lithium salt of N-[(1S,2S)-1-(benzyloxycarbonylamino-methyl)-2-hydroxy-pent-3-ynyl]-malonamic acid (151 mg, 0.43 mmol, see procedure 21a), N, N-diisopropylethylamine (0.38 mL, 2.1 mmol) and HATU (194 mg, 0.51 mmol). The mixture was stirred for 12 h at RT, concentrated in vacuo, and partitioned between EtOAc and sat. NH4Cl. The aqueous phase was extracted with EtOAc (1×). The combined organic extracts were washed with sat. NaHCO3 and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The residue was purified by flash chromatography to afford {(2S,3S)-2-[2-(5-tert-butyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-acetylamino]-3-hydroxy-hex-4-ynyl}-carbamic acid benzyl ester as a colorless oil (90 mg, 43% yield). MS found: (M+Na)+=510.4. (23b) A solution of {(2S,3S)-2-[2-(5-tert-butyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-acetylamino]-3-hydroxy-hex-4-ynyl}-carbamic acid benzyl ester (90 mg, 0.19 mmol) in MeOH (4 mL) was charged with 5% Pd/C, Degussa style (18 mg), stirred under H2 (1 atm) for 12 h at RT, filtered, and concentrated in vacuo. The residue was dissolved in MeOH (3 mL). The resultant solution was charged sequentially with 2,4-dimethylbenzaldehyde (0.02 mL, 0.14 mmol) and sodium cyanoborohydride (11 mg, 0.18 mmol), stirred for 12 h at RT, quenched with sat. NaHCO3, and extracted twice with EtOAc. The organic extracts were combined, washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo. Purification of the residue by reverse-phase HPLC provided the title compound as a white powder after lyopholization. MS found: (M+H)+=476.5.
Workup
- filtrationfiltered
- concentrationconcentrated in vacuo
- dissolutionThe residue was dissolved in MeOH (3 mL)
- stirringstirred for 12 h at RT
- customquenched with sat. NaHCO3
- extractionextracted twice with EtOAc
- washwashed with brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification of the residue by reverse-phase HPLC
Sources & evidence
- ORD record
- ord-400d1ffaa6b34ab2a59491701cb8f46f
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07468440B2
Reaction notes
Loading…